Oncternal Therapeutics ONCT

$ 0.53 -24.12%

Quarterly report 2024-Q3
added 11-06-2024

Oncternal Therapeutics Cash and Cash Equivalents 2011-2024 | ONCT

Annual Cash and Cash Equivalents Oncternal Therapeutics

2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
6.7 M	37.1 M	90.8 M	117 M	20.1 M	28.3 M	15.8 M	8.91 M	14.1 M	17.9 M	14.5 M	48 M	63.7 M

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
117 M	6.7 M	37.1 M

Quarterly Cash and Cash Equivalents Oncternal Therapeutics

2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
13.1 M	6.38 M	6.4 M	6.7 M	14.9 M	15.8 M	11.2 M	37.1 M	70.6 M	78.9 M	82.2 M	90.8 M	97.4 M	104 M	111 M	117 M	117 M	117 M	117 M	20.1 M	20.1 M	20.1 M	20.1 M	20.6 M	20.6 M	20.6 M	28.3 M	15.8 M	15.8 M	15.8 M	15.8 M	8.91 M	8.91 M	8.91 M	8.91 M	14.1 M	14.1 M	14.1 M	14.1 M	17.9 M	17.9 M	17.9 M	17.9 M	14.5 M	14.5 M	14.5 M	14.5 M	48 M	48 M	48 M	48 M	63.7 M	63.7 M	63.7 M	63.7 M

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
117 M	6.38 M	38.5 M